Comparing Costs of Radical Versus Partial Cystectomy for Patients Diagnosed With Localized Muscle-Invasive Bladder Cancer: Understanding the Value of Surgical Care.


Journal

Urology
ISSN: 1527-9995
Titre abrégé: Urology
Pays: United States
ID NLM: 0366151

Informations de publication

Date de publication:
01 2021
Historique:
received: 27 05 2020
revised: 21 07 2020
accepted: 09 08 2020
pubmed: 28 9 2020
medline: 4 2 2022
entrez: 27 9 2020
Statut: ppublish

Résumé

To compare costs associated with radical versus partial cystectomy. Prior studies noted substantial costs associated with radical cystectomy, however, they lack surgical comparison to partial cystectomy. A total of 2305 patients aged 66-85 years diagnosed with clinical stage T2-4a muscle-invasive bladder cancer from January 1, 2002 to December 31, 2011 were included. Total Medicare costs within 1 year of diagnosis following radical versus partial cystectomy were compared using inverse probability of treatment-weighted propensity score models. Cox regression and competing risks analysis were used to determine overall and cancer-specific survival, respectively. Median total costs were not significantly different for radical than partial cystectomy in 90 days ($73,907 vs $65,721; median difference $16,796, 95% CI $10,038-$23,558), 180 days ($113,288 vs $82,840; median difference $36,369, 95% CI $25,744-$47,392), and 365 days ($143,831 vs $107,359; median difference $34,628, 95% CI $17,819-$53,558), respectively. Hospitalization, surgery, pathology/laboratory, pharmacy, and skilled nursing facility costs contributed largely to costs associated with either treatment. Patients who underwent partial cystectomy had similar overall survival but had worse cancer-specific survival (Hazard Ratio 1.45, 95% Confidence Interval, 1.34-1.58, P < .001) than patients who underwent radical cystectomy. While treatments for bladder cancer are associated with substantial costs, we showed radical cystectomy had comparable total costs when compared to partial cystectomy among patients with muscle-invasive bladder cancer. However, partial cystectomy resulted in worse cancer-specific survival further supporting radical cystectomy as a high-value surgical procedure for muscle-invasive bladder cancer.

Identifiants

pubmed: 32980405
pii: S0090-4295(20)31169-9
doi: 10.1016/j.urology.2020.08.058
pii:
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

127-134

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Iyla Bagheri (I)

Department of Surgery, Division of Urology, The University of Texas Medical Branch, Galveston, TX.

Yong Shan (Y)

Department of Surgery, Division of Urology, The University of Texas Medical Branch, Galveston, TX.

Zachary Klaassen (Z)

Department of Surgery, Section of Urology, Medical College of Georgia, Augusta University, Augusta, GA.

Ashish M Kamat (AM)

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.

Badrineth Konety (B)

Department of Urology, University of Minnesota, Minneapolis, MN.

Hemalkumar B Mehta (HB)

Department of Epidemiology, Johns Hopkins University, Baltimore, MD.

Jacques G Baillargeon (JG)

Department of Medicine, Division of Epidemiology, Sealy Center on Aging, The University of Texas Medical Branch at Galveston, Galveston, TX.

Sunay Srinivas (S)

Department of Surgery, Division of Urology, The University of Texas Medical Branch, Galveston, TX.

Douglas S Tyler (DS)

Department of Surgery, The University of Texas Medical Branch, Galveston, TX.

Todd A Swanson (TA)

Department of Radiation Oncology, The University of Texas Medical Branch, Galveston, TX.

Sapna Kaul (S)

Department of Preventive Medicine and Community Health, The University of Texas Medical Branch at Galveston, Galveston, TX.

Brent K Hollenbeck (BK)

Department of Urology, University of Michigan, Ann Arbor, MI.

Stephen B Williams (SB)

Department of Surgery, Division of Urology, The University of Texas Medical Branch, Galveston, TX. Electronic address: stbwilli@utmb.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH